EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $20.75. This is a potential upside of $10.86 (109.81%) from yesterday's end of day stock price of $9.89.

Emergent Biosolutions's activity chart (see below) currently has 79 price targets and 56 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.81% with an average time for these price targets to be met of 102.18 days.

Highest price target for EBS is $15, Lowest price target is $12, average price target is $13.5.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Sep-2025. First documented stock forecast 26-Sep-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$6.09 (68.35%)

$15

1 months 5 days ago
(03-Sep-2025)

0/7 (0%)

$7.17 (91.57%)

Buy

$12

$3.09 (34.68%)

$8

11 months 1 days ago
(07-Nov-2024)

7/11 (63.64%)

$1 (9.09%)

23

Hold

$15

$5.85 (63.93%)

2 years 4 months 20 days ago
(18-May-2023)

4/7 (57.14%)

$6.83 (83.60%)

86

Sell

$9

$-0.15 (-1.64%)

$57

2 years 6 months 22 days ago
(16-Mar-2023)

2/3 (66.67%)

$0.88 (10.84%)

7

Buy

$55

$45.85 (501.09%)

2 years 11 months ago
(08-Nov-2022)

2/7 (28.57%)

$42.15 (328.02%)

217

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 102.18 days on average for the stock forecasts to be realized with a an average price target met ratio 69.81

Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 2 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with highest potential upside - $91.85

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

Jessica Fye with lowest potential downside - -$0.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?